Xconomy National

Archives

by in

Entry	Author	Date	Location
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership	Luke Timmerman	01/17/12	San Francisco
Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms	Luke Timmerman	01/05/12	Seattle
Dendreon Edges Past Street Expectations With Third Quarter Provenge Sales, Shares Still Fall	Luke Timmerman	11/02/11	Seattle
Exelixis To Push Ahead on Prostate Cancer Trial Without FDA Agreement: Shares Plunge	Luke Timmerman	10/31/11	San Francisco
Exelixis Passes Key Test With Lead Drug; Stock Soars	Luke Timmerman	10/24/11	San Francisco
Mascoma Seeks IPO, Tokai Takes in $23M, Boston-Power Gets $125 for Shift to China, & More Boston-Area Deals News	Erin Kutz	09/21/11	Boston
Dendreon Concentrates Job Cuts in Manufacturing, but Seattle Feels the Axe Too	Luke Timmerman	09/08/11	Seattle
Dendreon Whacks 500 Jobs, 25% of Workforce, After Missing Sales Goal	Luke Timmerman	09/08/11	Seattle
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News	Luke Timmerman	09/08/11	Seattle
Dendreon Wins FDA OK for Atlanta Provenge Factory, Completing National Network	Luke Timmerman	08/26/11	Seattle
Genomatica Files for IPO, Tandem Diabetes Raises $12M, Zogenix Looks to Raise Almost $50M, & More San Diego Life Sciences News	Bruce V. Bigelow	08/25/11	San Diego
Dendreon Adds Ex-ImClone CEO to Board	Luke Timmerman	08/22/11	Seattle
Dendreon’s Blow-Up, Epigenomics Leaves Town, Presage Adds $1.5M, & More Seattle-Area Life Sciences News	Luke Timmerman	08/11/11	Seattle
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus	Luke Timmerman	08/08/11	National
An Open Letter to Dendreon’s Chairman	Brad Loncar	08/05/11	Seattle
OncoGenex Drops on Trial Delay	Luke Timmerman	08/05/11	Seattle
Dendreon Takes Huge Hit, Stock Tanks 60% on Sales Shortfall	Luke Timmerman	08/03/11	Seattle
Dendreon, After Yearlong Inquiry, Sways Medicare to Pay for $93,000 Prostate Cancer Drug	Luke Timmerman	06/30/11	Seattle
Gates Bets on Computer Drug Discovery, Tachi Yamada Joins Frazier, Dendreon’s LA OK, & More in Seattle-Area Life Sciences News	Luke Timmerman	06/30/11	Seattle
Dendreon Gets FDA Nod for New LA Cancer Drug Factory	Luke Timmerman	06/29/11	Seattle
Exelixis Zeroes in on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients	Luke Timmerman	06/06/11	San Francisco
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer	Luke Timmerman	05/24/11	Seattle
The Resurgence of Gene and Cell Therapy	Barrie Carter	05/16/11	Seattle
Varian Invests $15M in Augmenix	Luke Timmerman	05/12/11	Boston
Dendreon Gets $28M Revenue in Q1	Luke Timmerman	05/02/11	Seattle
J&J Wins Early Approval of Potential Prostate Cancer Blockbuster	Arlene Weintraub	04/29/11	New York
San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors	Bruce V. Bigelow	04/27/11	San Diego
Medivation Flunks Huntington’s Trial, Calibra Nabs Venture Cash, Open Source Biology Comes to SF, & More Bay Area Life Sciences News	Luke Timmerman	04/15/11	San Francisco
T2 Biosystems, On-Q-ity, and GnuBIO Report Progress in Hunting for Signs of Disease	Ryan McBride	04/07/11	Boston
Dendreon Wins Full Reimbursement From Medicare for $93K Prostate Cancer Drug	Luke Timmerman	03/30/11	Seattle
Page 1 of 6	next page »